Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correction
出版年份 2015 全文链接
标题
Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correction
作者
关键词
-
出版物
Expert Review of Respiratory Medicine
Volume 10, Issue 1, Pages 5-17
出版商
Informa UK Limited
发表日期
2015-11-19
DOI
10.1586/17476348.2016.1122527
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis
- (2014) Penny Whiting et al. HEALTH TECHNOLOGY ASSESSMENT
- Cystic fibrosis: An inherited disease affecting mucin-producing organs
- (2014) Camille Ehre et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis
- (2014) M. J. Hoegger et al. SCIENCE
- CFTR Potentiators: Not an Open and Shut Case
- (2014) J. P. Clancy Science Translational Medicine
- Some gating potentiators, including VX-770, diminish F508-CFTR functional expression
- (2014) G. Veit et al. Science Translational Medicine
- Potentiator ivacaftor abrogates pharmacological correction of F508 CFTR in cystic fibrosis
- (2014) D. M. Cholon et al. Science Translational Medicine
- Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Eitan Kerem et al. Lancet Respiratory Medicine
- A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
- (2014) Michael P Boyle et al. Lancet Respiratory Medicine
- Lung Clearance Index as an Outcome Measure for Clinical Trials in Young Children with Cystic Fibrosis. A Pilot Study Using Inhaled Hypertonic Saline
- (2013) Padmaja Subbarao et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with aG551DMutation
- (2013) Jane C. Davies et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Editorial (Hot Topic:Cystic Fibrosis: CFTR Modulators and their Mechanism of Action)
- (2013) Erika Nieddu CURRENT PHARMACEUTICAL DESIGN
- Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs
- (2013) David A. Stoltz et al. JOURNAL OF CLINICAL INVESTIGATION
- Normal mucus formation requires cAMP-dependent HCO3−secretion and Ca2+-mediated mucin exocytosis
- (2013) Ning Yang et al. JOURNAL OF PHYSIOLOGY-LONDON
- A functional CFTR assay using primary cystic fibrosis intestinal organoids
- (2013) Johanna F Dekkers et al. NATURE MEDICINE
- Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications
- (2013) Malena Cohen-Cymberknoh et al. THORAX
- Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
- (2012) Patrick A. Flume et al. CHEST
- Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways
- (2012) M Kesimer et al. Mucosal Immunology
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for theF508del-CFTRmutation
- (2011) J P Clancy et al. THORAX
- CFTR: folding, misfolding and correcting the ΔF508 conformational defect
- (2011) Gergely L. Lukacs et al. TRENDS IN MOLECULAR MEDICINE
- Role of epithelial HCO3− transport in mucin secretion: lessons from cystic fibrosis
- (2010) Paul M. Quinton AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Loss of Cystic Fibrosis Transmembrane Conductance Regulator Function Produces Abnormalities in Tracheal Development in Neonatal Pigs and Young Children
- (2010) David K. Meyerholz et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia
- (2010) Jeng-Haur Chen et al. CELL
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional Stability of Rescued ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator in Airway Epithelial Cells
- (2009) Asta Jurkuvenaite et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Pharmaceuticals Targeting Nonsense Mutations in Genetic Diseases
- (2009) Steven M. Rowe et al. BIODRUGS
- BAP31 Interacts with Sec61 Translocons and Promotes Retrotranslocation of CFTRΔF508 via the Derlin-1 Complex
- (2008) Bing Wang et al. CELL
- Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis
- (2008) Paul M Quinton LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search